D-0374-2024 Class II Terminated
FDA drug recall D-0374-2024 was initiated by Thea Pharma, Inc. on Mar 5, 2024 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Out of specification for volume and compromised container closure. The recall status is terminated (terminated Jun 30, 2025). Affected quantity: 5,476 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 20, 2024
- Initiation Date
- Mar 5, 2024
- Termination Date
- Jun 30, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,476 bottles
Product description
Betimol (timolol ophthalmic solution) 0.5%, 15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15
Reason for recall
Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.
Distribution pattern
Product was distributed nationwide within the United States
Code information
Lot #: 435019, Exp. Date 11/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0374-2024
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026